AMZN
Amazon.com, Inc.
AMZN has the edge over BALY overall, supported by lower modeled downside and stronger valuation.
BALY
Bally's Corporation
BALY trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BALY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Weak |
BALY's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
BALY PE Valuation
BALY has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over BALY on the outlook, with more favorable earnings and profitability expectations.
BALY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect BALY's losses to grow, with revenue growing.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BALY on earnings quality, reporting a profit while its opponent remains loss making.
BALY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$12.64 | -$2.59 |
| Q1 2026 | -$13.99 | -$6.46 |
| Q4 2025 | -$10.73 | +$0.98 |
| Q3 2025 | -$6.65 | +$8.42 |
| Q2 2025 | -$10.05 | +$1.07 |
| Q1 2025 | -$7.53 | +$2.83 |
| Q4 2024 | -$11.71 | -$8.20 |
| Q3 2024 | -$15.07 | -$8.34 |
BALY is still losing money, but less than at its worst: $12.64 per share over the past year, against $15.07 at its worst in late 2024.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BALY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BALY on profitability, with a higher operating margin.
BALY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $792.2M | +20% |
| Q1 2026 | $755.7M | +105% |
| Q4 2025 | $746.2M | +29% |
| Q3 2025 | $663.7M | +5.4% |
| Q2 2025 | $657.5M | +5.8% |
| Q1 2025 | $368.7M | -40% |
| Q4 2024 | $580.4M | -5.1% |
| Q3 2024 | $630M | -0.4% |
BALY's revenue has grown year over year for five quarters in a row: $792M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4.3% | -3.9 points |
| Q1 2026 | 12% | +13 points |
| Q4 2025 | -37% | -31 points |
| Q3 2025 | 0.1% | +25 points |
| Q2 2025 | -0.4% | -1.3 points |
| Q1 2025 | -0.5% | +12 points |
| Q4 2024 | -5.6% | +46 points |
| Q3 2024 | -25% | -31 points |
BALY's operating margin was −4.3% last quarter, down 3.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BALY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$156M | -$123.8M |
| Q1 2026 | -$183.9M | -1693% |
| Q4 2025 | -$18.9M | -$12.7M |
| Q3 2025 | -$139.3M | -$83.5M |
| Q2 2025 | -$32.2M | -372% |
| Q1 2025 | $11.5M | +$47.5M |
| Q4 2024 | -$6.2M | -125% |
| Q3 2024 | -$55.8M | +$36.5M |
BALY has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BALY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +340K shares |
| 1 year | -0.2% | -98K shares |
| 3 years | +10% | +5.5M shares |
| 5 years | +69% | +24.8M shares |
| Available history | +60% | +22.7M shares |
BALY has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $416.2M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over BALY on leverage, with a lower net debt burden relative to earnings.
BALY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 28.0x | High |
| Q1 2026 | 24.2x | High |
| Q4 2025 | 240.2x | High |
| Q3 2025 | 15.9x | High |
| Q2 2025 | 51.6x | High |
| Q1 2025 | 40.0x | High |
| Q4 2024 | 26.0x | High |
| Q2 2024 | 39.9x | High |
BALY's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BALY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.9 | Neutral |
| Stochastic | 65.0 | Neutral |
BALY's weekly RSI is 45 (neutral) and its Stochastic is 65 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BALY PE vs Consumer Cyclical Sector
| Metric | BALY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BALY has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BALY on trend strength, trading above more of its moving averages.
BALY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 13% below |
| 20 week MA | $12.6 | 8.2% below |
| 50 week MA | $13.5 | 15% below |
| 100 week MA | $13.6 | 15% below |
| 200 week MA | $14.2 | 19% below |
BALY is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BALY on returns for 2026, with the stronger performance.
BALY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.9 | $48.8 | +88% |
| 2021 | $48.8 | $37.5 | -23% |
| 2022 | $37.5 | $19.4 | -48% |
| 2023 | $19.4 | $13.9 | -28% |
| 2024 | $13.9 | $17.8 | +28% |
| 2025 | $17.8 | $17.8 | -0.4% |
| 2026 YTD | $17.8 | $11.5 | -35% |
BALY has finished lower in four of the last six years. It's down 35% so far in 2026.